Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1119.2000 -9.70 (-0.86%)
NSE Sep 19, 2025 15:31 PM
Volume: 959.0K
 

1119.20
-0.86%
Prabhudas Lilladhar
CAPA completed for Unit-I, IX, VII and XI. Awaiting USFDA inspection. We upgrade ARBP rating to Accumulate (earlier Hold) as we increase the multiple assigned on FY23E to 15x (PE) v/s earlier 13x. This multiple re-rating...
Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended